Freddie Fu, M.D., professor and chair of Orthopaedic Surgery at the University of Pittsburgh School of Medicine, has been recognized by The European Federation of National Associations of Orthopaedics and Traumatology (EFORT) for his career-long contributions to international orthopedics. EFORT, an entity with 41 national member societies from 39 member countries, was founded in 1991 to link the orthopedic associations all across Europe.
Another Award and Recognition for the Inimitable Freddie Fu, M.D.
1 min read Premium comments
#freddiefu#efort
This year—the organization’s 30th anniversary—EFORT selected Dr. Fu to present the Michael Freeman Honorary Lecture during the organization’s virtual annual meeting. In addition, he gave a lecture titled, “Is the Latest Always the Greatest?” where he discussed innovation and new technologies as necessary ways to achieve health care advances. Dr. Fu also reviewed several past innovations, discussing how many have been ineffective, and at times harmful.
With the bestowing of this honor, Dr. Fu has now amassed more than 260 professional awards and honors, done over 1,200 national and international presentations, co-authored 173 book chapters, wrote over 675 peer-reviewed articles and edited 30 major orthopaedic textbooks. In 2019 Dr. Fu was named the most published author with 378 publications on the anterior cruciate ligament (ACL).
We asked our dear friend, Dr. Fu, about his greatest contribution to international orthopedics, Dr. Fu stated, “To train the next generations of orthopaedic surgeons, helping them to reach their maximum potential.”
Dr. Fu was one of three distinguished surgeons to receive this honor, along with Dr. Gilles Walch (France) and Dr. Reinhard Windhager (Austria).
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.